Therapy of MS
R Vosoughi, MS Freedman - Clinical neurology and neurosurgery, 2010 - Elsevier
The era of disease-modifying drugs (DMDs) in multiple sclerosis (MS) treatment began in
the 1990s, first with interferon-β (IFNβ), and the number of agents has increased steadily …
the 1990s, first with interferon-β (IFNβ), and the number of agents has increased steadily …
The clinical usefulness of routine MRI assessment
Although the diagnostic value of magnetic resonance imaging (MRI) in multiple sclerosis
(MS) is widely accepted, the clinical usefulness of routine MRI for monitoring the evolution of …
(MS) is widely accepted, the clinical usefulness of routine MRI for monitoring the evolution of …
Pseudoatrophy of the brain in multiple sclerosis: the effect of therapy on T1 measures of brain water content
EC Mackie - 2010 - open.library.ubc.ca
Abstract Magnetic Resonance Imaging (MRI) measures of T₁ relaxation provide a sensitive
and reproducible measure of water content in vivo. In the present study T₁ histograms were …
and reproducible measure of water content in vivo. In the present study T₁ histograms were …
[PDF][PDF] Recent Advances in the Management of Multiple Sclerosis
C Pozzilli, L Prosperini - The European Neurological Journal, 2010 - researchgate.net
Over the last few decades, there have been significant advances in the diagnosis and
management of multiple sclerosis (MS), and treatment options for MS have broadened …
management of multiple sclerosis (MS), and treatment options for MS have broadened …